Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.

Ferrari, Michel D; Färkkilä, Markus; Reuter, Uwe; Pilgrim, Alison; Davis, Charles; Krauss, Martin; Diener, Hans-Christoph

Ferrari, Michel D; Färkkilä, Markus; Reuter, Uwe; Pilgrim, Alison; Davis, Charles; Krauss, Martin; Diener, Hans-Christoph.

Affiliation

Ferrari MD; Leiden University Medical Centre, The Netherlands.

Cephalalgia ; 30(10): 1170-8, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20855362

Subject(s)

Benzamides/therapeutic use; Indoles/therapeutic use; Migraine Disorders/drug therapy; Serotonin Receptor Agonists/therapeutic use; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Receptors, Serotonin/drug effects; Young Adult; Receptor, Serotonin, 5-HT1F

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzamides / Serotonin Receptor Agonists / Indoles / Migraine Disorders Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Cephalalgia Year: 2010 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google